Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T20:27:52.534Z.
Calculation as of: 2026-10-06T20:27:52.534Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f2bd7b982a7c38b7b5dde5784864fe9761ce9be9b841b4296251164aedb1f89c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$62.78M
Free Cash Flow Yield
N/A
TTM Avg
74.97%
3Y Avg
74.97%
5Y Avg
74.97%
Market Cap
$63.02M
Free Cash Flow Yield
11.66%
TTM Avg
14.89%
3Y Avg
14.89%
5Y Avg
6.73%
Market Cap
$63.78M
Free Cash Flow Yield
N/A
TTM Avg
3.20%
3Y Avg
3.20%
5Y Avg
3.20%
Market Cap
$60.02M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.85M
Free Cash Flow Yield
N/A
TTM Avg
24.06%
3Y Avg
24.06%
5Y Avg
24.06%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | $62.62M | N/A | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | N/A | 74.97% | 74.97% | 74.97% |
| InterCure Ltd. (INCR)vs › | $63.02M | 11.66% | 14.89% | 14.89% | 6.73% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A | 3.20% | 3.20% | 3.20% |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A | 24.06% | 24.06% | 24.06% |
| Cingulate Inc. (CING)vs › | $65.86M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | 2.91% | 2.91% | 2.91% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
